• Home
  • Deal Card – Arcus

The Transaction

Delancey Street Partners is pleased to announce the following transaction:

October 2019
Arcus Global Media, LLC d.b.a. Arcus Medica

Sale to W2O, a portfolio company of New Mountain Capital
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to
Arcus Medica

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to Arcus Global Media, LLC d.b.a. Arcus Medica (“Arcus” or the “Company”) on its its sale to W2O Group (“W2O”), a portfolio company of New Mountain Capital (“New Mountain”). Delancey Street managed a competitive sell-side M&A process and negotiated the terms of the transaction.

Arcus Medica is a leading provider of outsourced medical and scientific communications services for pharmaceutical and biotechnology companies. Arcus specializes in transforming complex scientific and clinical data into effective messaging and multimedia plans, calibrated precisely for a variety of strategic goals and target audiences.

Arcus has developed and maintains strong and long-standing client relationships with Commercial Marketing and Medical Affairs divisions of the world’s leading life sciences companies. Clients seek out Arcus for its strategic knowledge and experience with products in the oncology, hematology and rare disease markets. These categories represent the largest and fastest growing in the industry, and are key areas of focus for biotechnology and pharmaceutical manufacturers. Arcus Medica was founded in 2014 and is based in Philadelphia, Pennsylvania.

W2O is a leading independent provider of analytics-driven, digital-first marketing services and communications to the healthcare sector. W2O applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. W2O maintains 15 offices across the United States and in Europe.

New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies.

Delancey Street Partners is an independent, industry-focused investment bank.  We serve CEOs, Entrepreneurs, Shareholders and Boards of Directors of high growth and middle market private and public companies.  Our services include strategic advisory, capital raising and independent board advice.  We advise on sell-side and buy-side M&A, growth capital financings and recapitalizations.  Our focus sectors include Healthcare, Business & Technology Services, Industrial & Industrial Technology, and Infrastructure.  We form long-term partnerships with our clients and commit to managing each engagement with senior professionals who bring years of experience and insight.

The transaction was completed October 1, 2019.

The principals of Delancey Street Partners have significant experience serving the Healthcare industry. To learn about our experience in Healthcare, please click here.

For additional information about this transaction, please contact:

B. Andrew Schmucker
Managing Partner

Delancey Street Partners

Our offices are located in the suburbs of Philadelphia:
Five Tower Bridge, Suite 420 | 300 Barr Harbor Drive | West Conshohocken, PA 19428
(484) 533-6300

© 2017 Delancey Street Partners, LLC | Disclosures

Securities offered through DSP Securities, LLC. Member SIPC | Member FINRA, all other transactions effectuated through Delancey Street Partners, LLC

Check the background of this investment professional on FINRA’s BrokerCheck »